Dr Simon Leigh; Director of Research; ORCHA Health Ltd and Susan Gallagher; Dietician and Clinical Lead for Diabetes at ORCHA; discuss the evidence-based benefits of using digital health technologies (DHTs); such as health apps; to support patients with type 1 and type 2 diabetes. This includes randomised controlled trials; published between 2010 and 2020; that measured HbA1c. This module explores how DHTs can reduce HbA1c levels; and how DHTs can support patients alongside medications and lifestyle interventions. Learn why DHTs are not just for young people; newly diagnosed patients or those who are inexperienced in living with diabetes.
ORCHA is the World’s leading health app evaluation and advisor organisation. We help governments, health and social care organisations to choose and deliver health apps that will safely make the biggest impact in terms of improving outcomes. Our tools help health professionals to prescribe and monitor usage of health apps. They’re proven to increase take-up and self-management of conditions.
Passionate about good apps, we provide a range of services to help app developers create better apps, and once great, get spotted by the people that matter.
This breakthrough approach to monitoring the market for new apps, evaluation and community adoption has won awards. We conduct reviews for NHS Digital and NHS England is accelerating the uptake of our service across the NHS, placing ORCHA in its National Innovation Accelerator Programme.
